Canada markets closed

Satellos Bioscience Inc. (MSCL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4200-0.0300 (-6.67%)
At close: 03:54PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 47.37M
Enterprise Value 721.61k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.02
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.05

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 382.61%
S&P500 52-Week Change 315.38%
52 Week High 30.8500
52 Week Low 30.2200
50-Day Moving Average 30.4100
200-Day Moving Average 30.4684

Share Statistics

Avg Vol (3 month) 342.89k
Avg Vol (10 day) 331.74k
Shares Outstanding 5112.79M
Implied Shares Outstanding 6120.85M
Float 888.05M
% Held by Insiders 116.87%
% Held by Institutions 12.32%
Shares Short (Nov 29, 2023) 440.67k
Short Ratio (Nov 29, 2023) 40.48
Short % of Float (Nov 29, 2023) 4N/A
Short % of Shares Outstanding (Nov 29, 2023) 40.04%
Shares Short (prior month Oct 30, 2023) 412.14k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Aug 17, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Sept 29, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.24%
Return on Equity (ttm)-52.88%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-67.63k
Net Income Avi to Common (ttm)-14.43M
Diluted EPS (ttm)-0.2500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.26M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.29
Book Value Per Share (mrq)0.41

Cash Flow Statement

Operating Cash Flow (ttm)-10.26M
Levered Free Cash Flow (ttm)-5.55M